Lee, Eung Gu
Kim, Youlim
Hwang, Yong Il
Yoo, Kwang Ha
Lee, So Eun
Jung, Kyung Yoon
Lee, Doik
Park, Yong Bum
Rhee, Chin Kook
Article History
Received: 6 December 2022
Accepted: 15 May 2023
First Online: 20 May 2023
Competing interests
: EGL and YIH have no conflict of interest. CKR received consulting and lecture fees from MSD, AstraZeneca, GlaxoSmithKline, Novartis, Takeda, Mundipharma, Boehringer-Ingelheim, TEVA, Sanofi, and Bayer. KHY has conducted clinical trials in Asthma, COPD, and Pneumonia with GlaxoSmithKline, AstraZeneca, Boehringer-Ingelheim, Novartis, Takeda, Nycomed, TEVA, MSD, Mundipharma, Hyundai Ankook, Chongkendang, Hanmi, and Hanlym. He received consulting fees from GlaxoSmithKline, AstraZeneca, Boehringer-Ingelheim, Novartis, Mundipharma, Ankook, Chongkendang, Hanmi, and Hanlym. YBP received consulting and lecture fees from AstraZeneca, GlaxoSmithKline, Novartis, Mundipharma, Boehringer-Ingelheim, and Sanofi. SEL was a former employee of Boehringer-Ingelheim Korea. KYJ was a former employee of Boehringer-Ingelheim Korea. YK received consulting and lecture fees from MSD, GlaxoSmithKline, Boehringer-Ingelheim, and Hanlim.